BIIB logo

Biogen Inc (BIIB)

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral scle...

NASDAQHealthcareDrug Manufacturers - GeneralUSA

Company Profile

Stock Code
BIIB
ISIN Code
US09062X1037
Currency
US Dollar (USD)
IPO Date
1991-09-16

Contact Information

Company Address
225 Binney Street, Cambridge, MA, United States, 02142
Contact Phone
617 679 2000
Company Website
https://www.biogen.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$999,999.99
Return on Assets (TTM)
5.21%
EBITDA
$999,999.99
Revenue (TTM)
$999,999.99